- Home
- TROO vs NVCT Comparison
TROO vs NVCT Comparison
Compare TROO & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TROO
- NVCT
- Stock Information
- Founded
- TROO 2005
- NVCT 2020
- Country
- TROO Hong Kong
- NVCT United States
- Employees
- TROO N/A
- NVCT N/A
- Industry
- TROO Radio And Television Broadcasting And Communications Equipment
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- TROO Technology
- NVCT Health Care
- Exchange
- TROO Nasdaq
- NVCT Nasdaq
- Market Cap
- TROO 169.8M
- NVCT 167.0M
- IPO Year
- TROO N/A
- NVCT 2022
- Fundamental
- Price
- TROO $1.19
- NVCT $5.65
- Analyst Decision
- TROO
- NVCT Strong Buy
- Analyst Count
- TROO 0
- NVCT 3
- Target Price
- TROO N/A
- NVCT $15.33
- AVG Volume (30 Days)
- TROO 265.3K
- NVCT 123.3K
- Earning Date
- TROO 12-04-2025
- NVCT 11-04-2025
- Dividend Yield
- TROO N/A
- NVCT N/A
- EPS Growth
- TROO N/A
- NVCT N/A
- EPS
- TROO N/A
- NVCT N/A
- Revenue
- TROO $15,084,000.00
- NVCT N/A
- Revenue This Year
- TROO N/A
- NVCT N/A
- Revenue Next Year
- TROO N/A
- NVCT N/A
- P/E Ratio
- TROO N/A
- NVCT N/A
- Revenue Growth
- TROO 247.24
- NVCT N/A
- 52 Week Low
- TROO $0.49
- NVCT $4.44
- 52 Week High
- TROO $3.05
- NVCT $11.80
- Technical
- Relative Strength Index (RSI)
- TROO 35.99
- NVCT 37.62
- Support Level
- TROO $1.48
- NVCT $5.61
- Resistance Level
- TROO $1.66
- NVCT $7.00
- Average True Range (ATR)
- TROO 0.11
- NVCT 0.37
- MACD
- TROO -0.05
- NVCT -0.03
- Stochastic Oscillator
- TROO 7.84
- NVCT 2.88
About TROO TROOPS Inc.
TROOPS Inc is a conglomerate group of various businesses with its headquarters based in Hong Kong. The group is principally engaged in money lending business in Hong Kong providing mortgage loans to high quality target borrowers, property investment to generate additional rental income and the development, operation and management of an online financial marketplace that provides one-stop financial technology solutions including API services by leveraging artificial intelligence, large data and blockchain, and cloud computing (SaaS). It derives revenue from Hong Kong and Australia. Majority of its revenue generates from domestic market.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.